PMDD and Severe PMS: When Premenstrual Mood Changes Are a Diagnosable Disorder

Answer first: PMDD symptoms are more than a difficult few days before a period. Premenstrual dysphoric disorder, or PMDD, is a recurring pattern of severe mood and physical symptoms that appears before menstruation, eases soon after bleeding begins, is minimal after the period, and significantly disrupts daily life. Diagnosis requires the right symptom pattern and prospective daily tracking, usually across at least two menstrual cycles. Severe PMS can also impair life, but PMDD has a defined diagnostic structure. Symptoms that continue all month and worsen before a period may instead represent premenstrual exacerbation of depression, anxiety, bipolar disorder, obsessive-compulsive disorder, or another condition.

Educational disclaimer: This article provides general information. It cannot diagnose PMDD or determine the cause of your symptoms. Individual assessment by a qualified healthcare professional is needed. Dr. Dina Rezk Clinic provides gynaecology and women's-health consultation. It does not provide psychiatry, psychology, therapy, counselling, mental-health medication management, or emergency care.

If you are in immediate danger or someone's life is at risk in Saudi Arabia, call 997 for an ambulance, or go to the nearest hospital emergency department. Saudi official sources list 997 for ambulance emergencies (GOV.SA Emergency Contact Numbers; Saudi Red Crescent Authority).

Key takeaways

• PMDD is defined by timing, severity, functional impairment, and a symptom-free or near-symptom-free interval after menstruation, not by one dramatic premenstrual day.
• A 2024 systematic review found a pooled point prevalence of 3.2% when PMDD was confirmed through prospective monitoring over two cycles, compared with 7.7% when diagnosis was provisional and based on retrospective reporting (Thomas and colleagues).
• Diagnosis generally requires daily prospective tracking for at least two menstrual cycles. A questionnaire completed once cannot confirm PMDD (NHS).
• Symptoms present throughout the month but worse before a period may be premenstrual exacerbation of another disorder, which can need a different treatment plan (StatPearls).
• Guideline-level options include lifestyle support, cognitive behavioural therapy, SSRIs, and selected hormonal treatment. Specialist ovarian suppression or surgery is reserved for exceptional, treatment-resistant cases because the risks and fertility consequences are substantial (NHS).
• Suicidal thoughts require immediate action, even if they seem predictably premenstrual. Do not wait for bleeding to start or for another cycle to confirm the pattern.

What is the difference between PMS, severe PMS, and PMDD?

PMS describes recurring symptoms before a period. PMDD is a diagnosable disorder in which the premenstrual symptoms are predominantly emotional, severe, clearly cyclical, and disruptive. “Severe PMS” is often used informally for major impairment, but a clinician still needs to establish whether the formal PMDD pattern is present or whether another condition is worsening premenstrually.

Premenstrual syndrome can include bloating, breast tenderness, headaches, fatigue, appetite change, poor sleep, irritability, or feeling emotional in the days or weeks before menstruation. The NHS notes that most women experience PMS at some point, although the type and intensity vary (NHS PMS guidance). A few uncomfortable days do not automatically indicate a disorder.

PMDD sits at the severe end of the premenstrual-disorder spectrum. The NHS describes it as causing intense emotional and physical symptoms before a period that can make work, social life, and relationships difficult (NHS PMDD guidance). The difference is not that physical symptoms disappear. It is that marked mood symptoms, timing, and impairment form a repeated clinical pattern.

The PMDD vs PMS difference becomes clearest when you look at freedom and function. A useful comparison is freedom. With mild PMS, you may feel irritable or tired but can still make choices and carry out your usual roles. With a possible disorder, the same part of each cycle may repeatedly lead to missed work, conflict you struggle to control, withdrawal from family, inability to study, or thoughts that life is not worth living. Severity is measured by the cost to your life, not by whether someone else thinks the symptom sounds “normal.”

This table cannot diagnose you. Its purpose is to show why timing across the entire cycle matters.

How common is PMDD?

Confirmed PMDD appears less common than retrospective symptom surveys suggest. In a 2024 systematic review of 44 studies, 48 samples, and 50,659 participants, pooled point prevalence was 3.2% when diagnosis was confirmed prospectively over two cycles, compared with 7.7% for provisional retrospective diagnosis. (Thomas and colleagues)

When the reviewers restricted the analysis to community samples that applied diagnostic criteria strictly and used two cycles of monitoring, the pooled prevalence was 1.6% (Thomas and colleagues). The estimates varied substantially across studies, and the authors concluded that provisional diagnosis tends to inflate prevalence. That gap is clinically useful: remembering the worst week of the month can be accurate as a warning sign, yet memory alone does not reliably establish the complete month-to-month pattern.

Saudi studies show that premenstrual symptoms are commonly reported, but they should not be presented as a national PMDD estimate. One cross-sectional primary-care study of 506 women aged 18 to 40 in the Asir Region reported PMS in 72.9% using its study definition, while citing lower figures from studies in Dammam and Jeddah (2024 regional study). Different samples, instruments, and definitions explain part of the spread. These numbers describe reported PMS burden, not prospectively confirmed PMDD across Saudi Arabia.

How is PMDD diagnosed, and what are the diagnostic features?

PMDD is diagnosed when a characteristic group of mood and related symptoms recurs in the final part of the menstrual cycle, improves within days after menstruation begins, becomes minimal after the period, causes substantial distress or impairment, and is not better explained by another disorder. The pattern should be confirmed prospectively across at least two symptomatic cycles.

DSM-5 classifies PMDD among depressive disorders. Without reproducing the proprietary manual's text, the structure can be explained plainly. A clinician looks for all of the following (StatPearls):

1. A repeated late-cycle window. Symptoms become prominent in the final week before menstruation, start improving within a few days after bleeding begins, and are minimal or absent in the following week.
2. A qualifying symptom pattern. At least five symptoms are present overall, and at least one comes from the core mood group: marked mood swings, marked irritability or anger, depressed mood or hopelessness, or anxiety and tension.
3. Meaningful impairment. Symptoms interfere with work, study, usual social activities, or relationships, or cause clinically significant distress.
4. A better explanation has been considered. The pattern is not simply a premenstrual worsening of an existing depressive, anxiety, bipolar, obsessive-compulsive, trauma-related, personality, or other disorder.
5. Prospective confirmation. Daily observations across at least two cycles show that the remembered pattern is real. A provisional diagnosis may sometimes be discussed before tracking is complete, but it is not the same as confirmation.
6. Substance and medical causes have been reviewed. Medicines, substances, thyroid disease, anaemia, perimenopause, pregnancy-related change, and other relevant conditions may need consideration.

The number threshold is only one part of diagnosis. Five mild symptoms with no impairment do not make PMDD. Equally, severe suicidal thoughts or disabling rage deserve urgent assessment even before two cycles of tracking are finished. Safety takes priority over diagnostic neatness.

Which symptoms can occur?

PMDD can affect emotions, thinking, behaviour, sleep, appetite, and the body. The pattern matters more than any one symptom.

Core mood symptoms

• sudden mood shifts, tearfulness, or feeling acutely rejected;
• intense irritability, anger, or conflict that feels out of character;
• depressed mood, hopelessness, harsh self-criticism, or feeling worthless;
• marked anxiety, tension, agitation, or feeling “on edge.”

Other emotional, cognitive, and behavioural symptoms

• loss of interest in work, study, social contact, hobbies, or intimacy;
• trouble concentrating or making ordinary decisions;
• low energy or feeling physically slowed down;
• appetite change, cravings, overeating, or loss of appetite;
• sleeping much more, insomnia, repeated waking, or unrefreshing sleep;
• feeling overwhelmed, unable to cope, or out of control.

Physical symptoms

• breast tenderness or swelling;
• bloating or a sense of fluid retention;
• headache;
• joint or muscle pain;
• temporary weight fluctuation linked to fluid and appetite changes.

Suicidal thoughts can occur with PMDD and are listed by the NHS as a symptom requiring urgent help (NHS). They should never be dismissed as “just hormones.” A predictable monthly crisis is still a crisis.

How to track symptoms prospectively without copying a screening instrument

Prospective tracking means recording symptoms and function each day as they happen, rather than reconstructing the month from memory. Do this for at least two full menstrual cycles. The record should cover good days as carefully as bad days, because the symptom-light interval helps distinguish PMDD from an all-month disorder. (NHS)

You do not need to copy the Daily Record of Severity of Problems or any complete screening tool. A plain notebook, calendar, or private notes file can capture the clinical pattern without reproducing proprietary items or calculating a diagnostic score.

A simple daily record

Use one short entry each evening. Include:

• cycle information: date, first day of bleeding, bleeding present or absent;
• mood in your own words: low, anxious, irritable, emotionally changeable, or steady;
• function: whether symptoms changed work, study, prayer, caregiving, social contact, exercise, or conflict at home;
• sleep and appetite: approximate sleep quality and any clear appetite change;
• physical symptoms: pain, headache, breast tenderness, bloating, or other symptoms relevant to you;
• context: major stress, illness, travel, fasting, night shifts, medicine changes, alcohol or substance use, or an unusually poor night's sleep;
• safety: any thoughts of death, self-harm, suicide, or feeling unable to remain safe.

Keep the language consistent enough to compare days, but do not chase precision. “Irritable, argued with my sister, left work early” is more informative than a number with no context. “Fine” on symptom-light days is also valuable data.

What the clinician needs to see

At the end of each cycle, do not erase the daily detail and replace it with a single average. Mark:

1. the date symptoms first became noticeably different;
2. the worst days and what stopped you functioning;
3. when bleeding began;
4. when symptoms began to lift;
5. whether there was a clearly better week after the period;
6. whether the same sequence repeated in the next cycle.

A record that shows depression on most days, with a premenstrual spike, tells a different story from one showing marked symptoms only in the late luteal phase and near-complete remission afterward. Both patterns deserve care. They just may not have the same diagnosis.

What to bring so the appointment is useful

Bring the two-cycle record, menstrual dates, a complete medicines and supplements list, contraception details, pregnancy plans, previous mental-health diagnoses and treatments, relevant laboratory results, and two or three concrete examples of functional impact. If symptoms have affected safety, say so at the start rather than waiting for the clinician to reach that part of the history.

PMDD or premenstrual worsening of another disorder?

Premenstrual exacerbation means an existing condition is present throughout the cycle but becomes worse before menstruation. PMDD, by contrast, requires a prominent symptom-free or near-symptom-free interval after the period. This distinction is one of the main reasons prospective tracking is required. (StatPearls)

If you are asking “PMDD or depression?”, the days after menstruation are especially informative. Depression may become darker premenstrually, anxiety may become harder to control, OCD symptoms may intensify, and bipolar symptoms can vary with sleep and cycle changes. Chronic migraine, endometriosis, pelvic pain, irritable bowel symptoms, and fatigue can also worsen around menstruation. A premenstrual pattern does not automatically turn each condition into PMDD.

Ask two questions while reviewing your record:

• Do the symptoms meaningfully remit after the period? If low mood, anxiety, obsessional thoughts, or impaired function continue on most days, another disorder may be primary.
• Are the premenstrual symptoms qualitatively different? A person with stable anxiety might develop a separate, abrupt pattern of severe irritability and rejection sensitivity before menstruation. Coexisting PMDD and another disorder are possible, but careful assessment is needed.

Bipolar disorder needs particular caution. Antidepressant decisions should not be made from an online symptom list when there is a history of unusually elevated or irritable mood, sharply reduced need for sleep, racing thoughts, impulsive spending, risky behaviour, or previous antidepressant-related activation. Tell the assessing clinician about those episodes, even if they felt productive at the time.

What medical conditions can mimic or complicate PMDD?

There is no blood test that confirms PMDD. Tests are used selectively to look for other explanations or contributors when the history points that way. The assessment may include thyroid disease, iron deficiency anaemia, pregnancy, perimenopause, medication effects, heavy bleeding, pain disorders, and sleep disruption.

An overactive thyroid can cause anxiety, irritability, insomnia, fatigue, palpitations, tremor, heat intolerance, and weight change (NHS thyroid guidance). Iron deficiency anaemia can cause tiredness, breathlessness, palpitations, pallor, and headaches (NHS anaemia guidance). These conditions do not reproduce the full PMDD pattern reliably, but they can magnify distress and deserve treatment in their own right.

Changing cycle length, hot flushes, night sweats, new sleep disturbance, and symptoms that no longer follow a predictable monthly pattern may point toward perimenopause. NICE advises that perimenopause in otherwise healthy people aged 45 or over is usually identified from symptoms and menstrual change rather than broad hormone testing (NICE NG23). A single “normal” hormone result does not settle a complex mood question.

Also review:

• heavy menstrual bleeding, which can contribute to iron deficiency;
• severe period or pelvic pain, which warrants its own gynaecological assessment;
• migraine and other cyclical neurological symptoms;
• pregnancy possibility or recent pregnancy loss;
• sleep apnoea, restless legs, shift work, or sustained sleep deprivation;
• stimulant, caffeine, nicotine, alcohol, and recreational substance use;
• recent starts, stops, or changes in hormonal contraception, psychiatric medicine, thyroid medicine, steroids, or other prescriptions.

Do not stop prescribed medicine or hormonal contraception to “test” the diagnosis without the relevant prescriber. Abrupt changes can create withdrawal, relapse, unintended pregnancy, or a misleading cycle.

What should a proper assessment cover?

A good assessment should explain the pattern, rule out urgent risk, and identify which clinician owns each part of care. It should not end with “your hormones are unbalanced” or with a screening score presented as a diagnosis.

Expect discussion of:

1. Cycle timing. Age at onset, cycle length, regularity, bleeding, symptom onset, relief, and whether symptoms disappear after menstruation.
2. Daily function. Effects on work, education, caregiving, relationships, healthcare attendance, exercise, and worship.
3. Mental-health history. Depression, anxiety, bipolar symptoms, OCD, trauma, eating problems, previous treatment, family history, and any hospital care.
4. Safety. Suicidal thoughts, self-harm, aggression, inability to care for yourself or dependants, psychotic symptoms, or feeling unable to stay safe.
5. Reproductive context. Current contraception, pregnancy possibility, future pregnancy plans, postpartum history, and whether symptoms began after a pregnancy or returned when cycles resumed.
6. Physical health. Thyroid symptoms, heavy bleeding, anaemia clues, severe pain, migraine, perimenopausal symptoms, weight change, and sleep problems.
7. Medicines and substances. Prescriptions, over-the-counter products, supplements, caffeine, nicotine, alcohol, and other substances.
8. Prospective evidence. The daily record across at least two cycles, including symptom-light days and functional examples.

A screening or symptom-rating instrument can organize information, but one score cannot establish timing across two cycles, exclude another disorder, or assess medical contributors. This article deliberately does not reproduce the DRSP, its items, or any scoring cut-off.

Which PMDD treatment options are supported by guidelines?

Treatment is matched to severity, dominant symptoms, pregnancy plans, contraception needs, coexisting conditions, previous response, side effects, and preference. Options include practical lifestyle support, cognitive behavioural therapy, SSRIs, and selected hormonal treatment. Specialist ovarian suppression or surgery may be considered only after careful confirmation and failure of less invasive options.

ACOG's 2023 clinical practice guideline addresses pharmacological, psychological, exercise, nutritional, educational, and procedural options for premenstrual disorders, using a multimodal approach and shared decision-making (ACOG guideline record). The full recommendation text was not available in the project's fetched evidence set, so this guide does not claim a more specific ACOG ranking than the accessible record supports.

Lifestyle and symptom-planning support

Regular aerobic activity, consistent sleep opportunities, regular meals, less alcohol, and reducing excess caffeine may improve general wellbeing and some PMS symptoms. ACOG's patient guidance includes exercise and lifestyle measures for PMS (ACOG). Treat these as support, not as proof that severe symptoms are a lifestyle failure.

For a predictable high-risk week, reduce optional overload where possible, postpone major relationship decisions until the symptom-light phase, and tell one trusted person what warning signs mean you need help. This is not “giving in to hormones.” It is sensible planning around a documented recurrent condition.

Supplements are often marketed heavily. The NHS notes that evidence for commonly suggested supplements is limited and advises checking with a clinician or pharmacist because supplements can interact with medicines (NHS PMS guidance). This guide does not recommend vitamin B6, calcium, magnesium, herbal remedies, or any branded product as PMDD treatment.

Cognitive behavioural therapy

CBT can help a person identify predictable thoughts, behaviours, avoidance, and conflict patterns during symptomatic days, then practise responses that reduce harm. The NHS lists talking therapy such as CBT among PMDD treatments (NHS). Therapy should not be framed as evidence that the condition is imaginary. Psychological skills and biological sensitivity can both matter.

Dr. Dina Rezk Clinic does not provide CBT or other mental-health therapy. If you want this treatment, seek an appropriately qualified mental-health professional.

SSRIs

Selective serotonin reuptake inhibitors are an evidence-based medication option for PMDD. ACOG states that SSRIs can help some women with PMDD, and the NHS lists antidepressants among treatments (ACOG; NHS). Unlike many depressive disorders, PMDD treatment may sometimes use continuous dosing or a schedule tied to the symptomatic phase. The choice belongs to a qualified prescriber after diagnostic review. This guide gives no dose, brand, start date, or switching plan.

Before an SSRI is considered, tell the prescriber about bipolar symptoms, previous activation, suicidal thoughts, other medicines, bleeding risk, pregnancy plans, and prior withdrawal. Possible adverse effects can include nausea, sleep change, sexual side effects, agitation, and discontinuation symptoms. Do not start, stop, or alter an antidepressant based on this article.

Hormonal contraception

A combined oral contraceptive may help some people by suppressing ovulation and is listed by the NHS as a hormonal treatment for PMDD (NHS). It is not one uniform treatment: formulations, hormone-free intervals, contraindications, bleeding effects, and individual mood responses differ.

A clinician should review migraine with aura, smoking, blood-clot history or risk, blood pressure, breastfeeding, other health conditions, and medication interactions before recommending combined hormonal contraception. A person who needs reliable contraception may weigh benefits differently from someone trying to conceive. If mood worsened after a contraceptive change, record the timing and discuss it rather than stopping without a pregnancy-prevention plan.

Specialist suppression and surgery

If severe, prospectively confirmed PMDD remains disabling despite appropriate trials of standard options, a specialist may consider temporarily suppressing ovarian function with a GnRH analogue (gonadotropin-releasing hormone analogue). This can help test whether ovarian cycling is driving symptoms, but it can also cause menopause-like symptoms and affect bone health. Specialist oversight is essential.

The NHS notes that surgery to stop periods may be considered when other treatments have not worked, with procedures potentially involving removal of reproductive organs and making pregnancy impossible (NHS). Surgery should never be described as a quick “cure” for a diagnosis based only on recalled symptoms. Confirmation, psychiatric and gynaecological assessment, informed consent, fertility counselling, and careful evaluation of less invasive alternatives are necessary.

Contraception, pregnancy, and fertility planning

PMDD depends on menstrual cycling, so it does not present in its usual cyclical form during pregnancy. Symptoms may change when ovulation is suppressed, during pregnancy, postpartum, or when cycles resume. If pregnancy is possible or planned, every medication and hormonal option needs an individual review before treatment changes.

Do not assume that becoming pregnant will permanently cure PMDD. Pregnancy pauses menstrual cycling, but it also brings its own physical and mental-health risks. After birth, the return of ovulation may precede the first visible period, and mood symptoms in the postpartum months require assessment rather than automatic attribution to PMDD.

Before trying to conceive, discuss:

• which clinician currently prescribes each medicine;
• the risk of relapse if treatment changes;
• what is known about the specific medicine in pregnancy and breastfeeding;
• whether contraception is also serving as PMDD treatment;
• how symptoms and safety will be monitored if cycles return;
• who to contact if severe depression, agitation, sleeplessness, intrusive thoughts, or suicidal thoughts develop.

Do not stop an SSRI or hormonal method abruptly because of a positive pregnancy test without contacting the relevant prescriber promptly. The safest plan depends on the medicine, symptoms, pregnancy stage, alternatives, and risk of untreated illness.

What can you do while waiting for assessment?

Tracking is the most useful first step, but it is not the only one.

• Name the high-risk window. Share the approximate dates with one trusted person and explain which changes signal that you need contact or urgent help.
• Protect sleep where possible. Avoid scheduling optional late nights in the week when insomnia and irritability usually rise. Seek assessment if snoring, gasping, restless legs, or severe sleep loss is present.
• Lower preventable conflict. If safe, agree not to make irreversible relationship or financial decisions during the worst days. Revisit the issue in the symptom-light week.
• Prepare one appointment summary. Write when the pattern started, what changes across the cycle, two examples of impairment, relevant diagnoses, medicines, contraception, pregnancy plans, and your main question.
• Keep ordinary medical care moving. Heavy bleeding, severe pain, palpitations, weight change, or persistent fatigue should not wait simply because symptoms feel cyclical.
• Act on danger immediately. A safety plan is not “wait until morning.” If you cannot stay safe, use the emergency route now.

When a gynaecology consultation is, and is not, the right next step

A gynaecology or women's-health consultation can be useful when symptoms follow the menstrual cycle, bleeding is heavy or irregular, pelvic pain is present, contraception may be helping or worsening symptoms, cycles are changing in midlife, pregnancy is possible, or hormonal treatment is being considered. The consultation can review reproductive timing, medical contributors, relevant examination or testing, and whether another professional should lead part of care.

A mental-health assessment is also needed when depression, anxiety, OCD, trauma symptoms, bipolar features, self-harm, substance use, eating problems, or impaired function continue across the month. Psychiatric prescribing and psychological therapy sit outside Dr. Dina Rezk Clinic's stated scope. The right plan may involve both gynaecological and mental-health care, with each clinician responsible for their field.

For broader context on cycle-related mood, see Hormones and Mood. If anxiety persists throughout the month, see Anxiety in Women. The Women's Mental Health guide helps place PMDD within the wider cluster.

Frequently asked questions

The bottom line

PMDD is real, diagnosable, and treatable, but it cannot be confirmed by recognising a few familiar symptoms. The key evidence is a repeated late-cycle pattern, significant impact, relief after menstruation, and prospective daily observations across at least two cycles. That same record can reveal something equally valuable: depression, anxiety, bipolar disorder, OCD, pain, migraine, or another condition that worsens before a period but needs its own treatment plan.

Start tracking now if it is safe to wait, and bring cycle dates, functional examples, medicines, contraception, pregnancy plans, and mental-health history to the assessment. Seek both gynaecological and mental-health input when the picture crosses both fields. If suicidal thoughts or inability to stay safe appears, do not wait for a diagnostic diary to be complete. In Saudi Arabia, call 997 for an ambulance or go to the nearest hospital emergency department.

This article is educational and cannot determine the cause of an individual patient's symptoms without medical assessment.

References

1. Thomas I, et al. The prevalence of premenstrual dysphoric disorder: systematic review and meta-analysis. 2024. https://ora.ox.ac.uk/objects/uuid:1162daa2-1b17-4587-a3e1-c706493401a1/files/rxs55mc98w
2. StatPearls. Premenstrual Disorders. Updated 9 August 2026. https://www.ncbi.nlm.nih.gov/books/NBK532307/
3. NHS. Premenstrual dysphoric disorder. Updated 21 August 2026. https://www.nhs.uk/conditions/pmdd-premenstrual-dysphoric-disorder/
4. NHS. Premenstrual syndrome. https://www.nhs.uk/conditions/pre-menstrual-syndrome/
5. American College of Obstetricians and Gynecologists. Premenstrual Syndrome. https://www.acog.org/womens-health/faqs/premenstrual-syndrome
6. American College of Obstetricians and Gynecologists. Management of Premenstrual Disorders. Clinical Practice Guideline No. 7. 2023. https://pubmed.ncbi.nlm.nih.gov/37973069/
7. Alshahrani S, et al. Prevalence, Pattern, and Predictors of Premenstrual Syndrome Among Women Attending Primary Healthcare Centers in the Asir Region. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11358713/
8. National Institute for Health and Care Excellence. Menopause: identification and management. NICE guideline NG23. https://www.nice.org.uk/guidance/ng23/chapter/recommendations
9. NHS. Overactive thyroid: symptoms. https://www.nhs.uk/conditions/overactive-thyroid-hyperthyroidism/symptoms/
10. NHS. Iron deficiency anaemia. https://www.nhs.uk/conditions/iron-deficiency-anaemia/
11. Saudi Food and Drug Authority. Overview. https://www.sfda.gov.sa/en/overview
12. GOV.SA. Emergency Contact Numbers. https://my.gov.sa/en/emergency-contact
13. Saudi Red Crescent Authority. Contact Us. https://www.srca.org.sa/en/contact-us/
14. Saudi Ministry of Health. Contact Us and 937 Services. https://www.moh.gov.sa/en/ministry/about/pages/contactus.aspx and https://www.moh.gov.sa/en/937/pages/default.aspx
15. Saudi Ministry of Health. MOH and Psychiatric Patient. https://www.moh.gov.sa/en/ministry/information-and-services/pages/psychiatry.aspx
16. GOV.SA. Qareboon service. https://my.gov.sa/ar/services/116567